Nicole Germino
Stock Analyst at Truist Securities
(3.65)
# 792
Out of 5,012 analysts
22
Total ratings
63.16%
Success rate
30.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nicole Germino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $126 → $139 | $162.32 | -14.37% | 9 | Aug 14, 2025 | |
| CATX Perspective Therapeutics | Maintains: Buy | $10 → $8 | $3.47 | +130.55% | 3 | May 14, 2025 | |
| SGMO Sangamo Therapeutics | Maintains: Buy | $7 → $5 | $0.70 | +616.54% | 5 | Jan 23, 2025 | |
| ASMB Assembly Biosciences | Downgrades: Hold | $132 → $24 | $23.86 | +0.59% | 3 | Oct 24, 2022 | |
| FBRX Forte Biosciences | Downgrades: Hold | n/a | $14.23 | - | 2 | Sep 3, 2021 |
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $126 → $139
Current: $162.32
Upside: -14.37%
Perspective Therapeutics
May 14, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $3.47
Upside: +130.55%
Sangamo Therapeutics
Jan 23, 2025
Maintains: Buy
Price Target: $7 → $5
Current: $0.70
Upside: +616.54%
Assembly Biosciences
Oct 24, 2022
Downgrades: Hold
Price Target: $132 → $24
Current: $23.86
Upside: +0.59%
Forte Biosciences
Sep 3, 2021
Downgrades: Hold
Price Target: n/a
Current: $14.23
Upside: -